secwatch.observer — SEC 8-K summary
======================================

Issuer:     Microbot Medical Inc. (MBOT)
CIK:        0000883975
Form:       8-K
Filed at:   2026-05-26T12:30:22+00:00
Accession:  0001493152-26-025171
Event type: regulatory
Sentiment:  positive
Materiality: 0.70
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Microbot Medical receives Israeli regulatory approval for LIBERTY System, first outside U.S.
--------------------------------------------------------------------------------

- Israeli Ministry of Health's AMAR Division grants marketing clearance for LIBERTY Endovascular Robotic System in Israel.
- First regulatory approval outside the U.S.; enables Free Sale Certificate for submissions in other jurisdictions.
- Company targets CE Mark certification by end of 2026 for EU market expansion.
- System adopted by multiple U.S. accounts in GA, FL, NY, MA, MI, NC.
- Advanced discussions underway to expedite commercialization in Israel.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883975/000149315226025171/0001493152-26-025171-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883975/000149315226025171/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-025171

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer